Found: 7
Select item for more details and to access through your institution.
ERBB2 exon 20 insertions are rare in Brazilian non‐small cell lung cancer.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 23, p. 3402, doi. 10.1111/1759-7714.14605
- By:
- Publication type:
- Article
Impact of AferBio® on quality of life and chemotherapy toxicity in advanced lung cancer patients (AFERBIO study): protocol study for a phase II randomized controlled trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Feasibility of concomitant cisplatin with hypofractionated radiotherapy for locally advanced head and neck squamous cell carcinoma.
- Published in:
- BMC Cancer, 2018, v. 18, n. 1, p. 1, doi. 10.1186/s12885-018-4893-5
- By:
- Publication type:
- Article
Disruptive and Truncating TP53 Mutations Are Associated with African-Ancestry and Worse Prognosis in Brazilian Patients with Lung Adenocarcinoma.
- Published in:
- Pathobiology, 2023, v. 90, n. 5, p. 344, doi. 10.1159/000530587
- By:
- Publication type:
- Article
Molecular profile of driver genes in lung adenocarcinomas of Brazilian patients who have never smoked: implications for targeted therapies.
- Published in:
- Oncologist, 2024, v. 29, n. 10, p. e1419, doi. 10.1093/oncolo/oyae129
- By:
- Publication type:
- Article
EGFR Mutations and PD-L1 Expression in Early-Stage Non-Small Cell Lung Cancer: A Real-World Data From a Single Center in Brazil.
- Published in:
- Oncologist, 2022, v. 27, n. 11, p. e899, doi. 10.1093/oncolo/oyac167
- By:
- Publication type:
- Article
Detection of NTRK fusions by RNA-based nCounter is a feasible diagnostic methodology in a real-world scenario for non-small cell lung cancer assessment.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-48613-4
- By:
- Publication type:
- Article